动物保健市场分析及预测（至2035年）：类型、产品类型、服务、技术、应用、最终用户、设备、流程、解决方案

预计动物保健市场规模将从2024年的585亿美元成长到2034年的912亿美元，年复合成长率约为5.1%。动物保健市场涵盖旨在改善动物健康和福利的产品和服务，例如药品、疫苗、诊断试剂和饲料添加剂。该行业涵盖伴侣动物和牲畜，重点关注疾病的预防、治疗和管理。宠物饲养量的增长、畜牧业生产的扩张以及兽医技术的进步是推动该市场发展的关键因素，这些因素促进了生物製药和数位健康解决方案的创新，从而改善动物的护理和生产力。

动物保健市场正经历强劲成长，主要得益于动物医药和诊断技术的进步。製药领域是市场的主要驱动力，其中驱虫药和抗感染剂凭藉宠物饲养率的提高和人们对牲畜健康意识的增强，成为领先的细分市场。疫苗紧随其后，主要得益于动物预防性用药需求的成长。诊断领域发展势头强劲，分子诊断和免疫诊断是表现第二好的细分市场。这些技术提高了疾病检测的准确性，并有助于改善治疗效果。尤其值得一提的是，对伴侣动物诊断的需求正在上升，这反映了人类与宠物之间日益加深的关联。饲料添加剂领域，特别是营养补充品和生长促进剂领域，也不断扩张。这一增长的驱动力是提高动物生产力和健康水平的需求。此外，数位化动物保健解决方案的创新也为市场提供了支持，这些解决方案简化了兽医实践，提高了动物护理的效率。

动物用药品市场呈现市场占有率多元化的特点，成熟企业和新兴企业都在不断推出创新解决方案。定价策略反映了高级产品与经济实惠替代方案之间的平衡，以满足不同消费者的需求。近期产品推出凸显了药物和诊断工具的进步，强调了疗效的提升和使用者便利性的增强。这种充满活力的市场环境受到预防医学需求成长和宠物饲养趋势日益增长的影响。竞争基准分析显示，市场主要由少数主要企业主导，而新参与企业则透过提供利基产品来扩大市场份额。监管影响至关重要，北美和欧洲等地区对市场运作制定了严格的指导方针。亚太地区由于有利的法规结构和日益增强的动物健康意识，展现出巨大的发展潜力。市场分析预测，在技术整合和兽医服务投资增加的推动下，市场将维持强劲的复合年增长率。儘管监管合规和市场饱和等挑战依然存在，但生物製药和数位健康解决方案的创新提供了巨大的成长机会。

主要趋势和驱动因素：

受宠物主人数量不断增长和动物福利意识提升的推动，兽医保健市场正经历强劲增长。主要趋势包括对预防性保健和宠物健康产品的需求不断增长，这反映出动物照护正朝着预防为主的方向转变。兽医诊断技术和治疗方法的进步使得疾病的早期发现和有效治疗成为可能，从而改善了动物的整体健康。另一个关键驱动因素是对畜产品需求的成长，这反过来又需要改善畜牧管理实践和疾病控制。远端医疗和穿戴式装置等数位技术的应用正在透过实现即时监测和远距会诊，彻底改变动物保健产业。这些创新对农村和医疗服务不足的地区尤其有益。此外，旨在确保食品安全和防治通用感染疾病的监管支持和政府主导的措施也在推动市场成长。新兴市场畜牧业的快速发展蕴藏着许多机会。能够提供经济高效且创新解决方案的公司将占据有利地位，充分利用这些趋势，确保兽医保健行业的可持续成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

• 宏观经济分析
• 市场趋势
• 市场驱动因素
• 市场机会
• 市场限制
• 复合年均成长率：成长分析
• 影响分析
• 新兴市场
• 技术蓝图
• 战略框架

第四章 细分市场分析

• 市场规模及预测：依类型
  • 製药
  • 生物製药
  • 饲料添加剂
  • 疫苗
  • 诊断试剂
• 市场规模及预测：依产品划分
  • 抗感染药物
  • 驱虫药
  • 抗发炎药
  • 药品和饲料添加剂
  • 营养饲料添加剂
• 市场规模及预测：依服务划分
  • 兽医诊所
  • 移动兽医服务
  • 远端医疗
  • 动物康復
• 市场规模及预测：依技术划分
  • 分子诊断
  • 免疫诊断试剂
  • 临床生物化学
• 市场规模及预测：依应用领域划分
  • 伴侣动物
  • 家畜
  • 水产养殖
  • 鸟类
• 市场规模及预测：依最终用户划分
  • 兽医诊所
  • 畜牧场
  • 研究所
• 市场规模及预测：依设备划分
  • 手术器械
  • 影像设备
  • 监测设备
• 市场规模及预测：依製程划分
  • 药物研发
  • 疫苗生产
  • 饲料生产
• 市场规模及预测：按解决方案划分
  • 疾病管理
  • 集团管理

第五章 区域分析

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地区
• 亚太地区
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲
  • 台湾
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 其他欧洲地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 撒哈拉以南非洲
  • 其他中东和非洲地区

第六章 市场策略

• 需求与供给差距分析
• 贸易和物流限制
• 价格、成本和利润率趋势
• 市场渗透率
• 消费者分析
• 法规概述

第七章 竞争讯息

• 市场定位
• 市场占有率
• 竞争基准
• 主要企业的策略

第八章 公司简介

• Phibro Animal Health
• Vetoquinol
• Heska Corporation
• Neogen Corporation
• Dechra Pharmaceuticals
• Virbac
• Zoetis
• Elanco Animal Health
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• IDEXX Laboratories
• Bimeda
• Norbrook Laboratories
• Ourofino Saude Animal
• Kyoritsu Seiyaku
• Aratana Therapeutics
• Eco Animal Health
• Kraeber & Co
• Avivagen
• Pet IQ

第九章：关于我们

Animal Health Market is anticipated to expand from $58.5 billion in 2024 to $91.2 billion by 2034, growing at a CAGR of approximately 5.1%. The Animal Health Market encompasses products and services aimed at improving the health and well-being of animals, including pharmaceuticals, vaccines, diagnostics, and feed additives. This sector addresses both companion and livestock animals, focusing on disease prevention, treatment, and management. Rising pet ownership, increasing livestock production, and advancements in veterinary technology are key drivers, fostering innovation in biologics and digital health solutions to enhance animal care and productivity.

The Animal Health Market is experiencing robust growth, primarily driven by advancements in veterinary pharmaceuticals and diagnostics. The pharmaceuticals segment leads the market, with parasiticides and anti-infectives emerging as top-performing sub-segments due to increasing pet ownership and livestock health awareness. Vaccines follow closely, propelled by the rising demand for preventive care in animals. The diagnostics segment is gaining momentum, with molecular diagnostics and immunodiagnostics being the second highest performing sub-segments. These technologies offer precision in disease detection, enhancing treatment outcomes. Companion animal diagnostics are particularly in demand, reflecting the growing bond between humans and pets. The feed additives segment, focusing on nutritional supplements and growth enhancers, is also expanding. This growth is attributed to the need for improved animal productivity and health. The market is further supported by innovations in digital animal health solutions, which streamline veterinary practices and enhance animal care efficiency.

The Animal Health Market is characterized by a diverse market share, with established companies and emerging players introducing innovative solutions. Pricing strategies reflect a balance between premium products and cost-effective alternatives, catering to varied consumer needs. Recent product launches highlight advancements in pharmaceuticals and diagnostic tools, emphasizing enhanced efficacy and user convenience. This dynamic landscape is shaped by increasing demand for preventive care and the growing pet ownership trend. Competitive benchmarking reveals a concentrated market with a few dominant players, yet new entrants are gaining traction through niche offerings. Regulatory influences are pivotal, with stringent guidelines in regions like North America and Europe dictating market operations. The Asia-Pacific region exhibits significant potential due to favorable regulatory frameworks and increasing animal health awareness. Market analysis indicates a robust CAGR, driven by technological integration and rising investment in veterinary services. Challenges such as regulatory compliance and market saturation persist, yet innovation in biopharmaceuticals and digital health solutions presents substantial growth opportunities.

Geographical Overview:

The animal health market is witnessing robust growth across various regions, with each presenting unique opportunities. North America leads the market, driven by advanced veterinary healthcare infrastructure and increased pet ownership. The region's focus on preventative care and innovative treatments enhances its market position. Europe follows, with strong demand for livestock health products due to stringent regulatory standards and a focus on food safety. The region also benefits from a growing awareness of animal welfare. In Asia Pacific, rapid urbanization and rising disposable incomes are fueling market expansion. Countries like China and India are emerging as key growth pockets, with increasing investments in veterinary services and pharmaceuticals. Latin America and the Middle East & Africa are gaining traction, with a growing emphasis on livestock health to support agricultural productivity. Brazil and South Africa are notable emerging markets, recognizing the importance of animal health in economic development and food security.

The global animal health market is navigating a complex web of tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, strategies are increasingly focused on enhancing domestic production capabilities to mitigate tariff impacts and reduce reliance on imports. China is accelerating its investment in biotech innovation to counteract export restrictions and bolster self-sufficiency. Taiwan, while pivotal in biotechnology, faces geopolitical vulnerabilities due to its position in US-China trade disputes. The parent market is experiencing robust growth, driven by rising pet ownership and livestock health investments. By 2035, the market is poised for expansion, contingent on resilient supply chains and strategic partnerships. Additionally, conflicts in the Middle East may indirectly influence global supply chains and energy prices, impacting production costs and market stability.

Key Trends and Drivers:

The animal health market is experiencing robust growth, driven by increased pet ownership and heightened awareness of animal welfare. Key trends include the rise in preventive healthcare and wellness products for pets, reflecting a shift towards proactive animal care. Advances in veterinary diagnostics and therapeutics are enabling early disease detection and effective treatment, enhancing overall animal health outcomes. Another significant driver is the growing demand for livestock products, which necessitates improved animal husbandry practices and disease management. The integration of digital technologies, such as telemedicine and wearable devices, is revolutionizing animal healthcare by providing real-time monitoring and remote consultations. These innovations are particularly beneficial in rural and underserved areas. Additionally, regulatory support and government initiatives aimed at ensuring food safety and zoonotic disease control are bolstering market growth. Opportunities abound in emerging markets where the livestock industry is expanding rapidly. Companies that can offer cost-effective and innovative solutions are well-positioned to capitalize on these trends, ensuring sustainable growth in the animal health sector.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Process
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pharmaceuticals
  • 4.1.2 Biologics
  • 4.1.3 Feed Additives
  • 4.1.4 Vaccines
  • 4.1.5 Diagnostics
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Anti-Infectives
  • 4.2.2 Parasiticides
  • 4.2.3 Anti-Inflammatories
  • 4.2.4 Medicinal Feed Additives
  • 4.2.5 Nutritional Feed Additives
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Veterinary Clinics
  • 4.3.2 Mobile Veterinary Services
  • 4.3.3 Telemedicine
  • 4.3.4 Animal Rehabilitation
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Molecular Diagnostics
  • 4.4.2 Immunodiagnostics
  • 4.4.3 Clinical Biochemistry
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Companion Animals
  • 4.5.2 Livestock
  • 4.5.3 Aquaculture
  • 4.5.4 Avian
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Veterinary Hospitals
  • 4.6.2 Animal Farms
  • 4.6.3 Research Institutes
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Surgical Instruments
  • 4.7.2 Imaging Devices
  • 4.7.3 Monitoring Devices
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Drug Development
  • 4.8.2 Vaccine Production
  • 4.8.3 Feed Manufacturing
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Disease Management
  • 4.9.2 Herd Management

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Device
    • 5.2.1.8 Process
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Device
    • 5.2.2.8 Process
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Device
    • 5.2.3.8 Process
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Device
    • 5.3.1.8 Process
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Device
    • 5.3.2.8 Process
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Device
    • 5.3.3.8 Process
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Device
    • 5.4.1.8 Process
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Device
    • 5.4.2.8 Process
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Device
    • 5.4.3.8 Process
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Device
    • 5.4.4.8 Process
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Device
    • 5.4.5.8 Process
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Device
    • 5.4.6.8 Process
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Device
    • 5.4.7.8 Process
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Device
    • 5.5.1.8 Process
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Device
    • 5.5.2.8 Process
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Device
    • 5.5.3.8 Process
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Device
    • 5.5.4.8 Process
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Device
    • 5.5.5.8 Process
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Device
    • 5.5.6.8 Process
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Device
    • 5.6.1.8 Process
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Device
    • 5.6.2.8 Process
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Device
    • 5.6.3.8 Process
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Device
    • 5.6.4.8 Process
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Device
    • 5.6.5.8 Process
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Phibro Animal Health
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Vetoquinol
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Heska Corporation
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Neogen Corporation
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Dechra Pharmaceuticals
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Virbac
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Zoetis
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Elanco Animal Health
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Boehringer Ingelheim Animal Health
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Ceva Sante Animale
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 IDEXX Laboratories
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Bimeda
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Norbrook Laboratories
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Ourofino Saude Animal
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Kyoritsu Seiyaku
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Aratana Therapeutics
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Eco Animal Health
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Kraeber & Co
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Avivagen
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Pet IQ
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us